Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 93 results for "dpco"

NPPA revises prices of 33 more formulations under new DPCO norms

Continuing further its process of revising the prices of essential medicines in line with the new Drug Price Control Order (DPCO), the National Pharmaceutical Pricing Authority (NPPA) has fixed the prices of 33 more formulation packs. With this, ... PharmaBiz, 2 weeks ago
"Market-Based" Price Controls in India? Pharmaceutical Executive, 2 weeks ago

8 images for dpco

Business Standard India, 3 months ago, 3 months ago
Business Standard India, 3 months ago
Bio Spectrum Asia, 4 months ago
Business Standard India, 4 months ago
Money Life, 4 months ago
Money Life, 4 months ago
Times of India, 4 months ago
Business Standard

Pharma SMEs from Gujarat see 20% growth in exports

Focus on exports as domestic market becomes competitive with DPCO 2013 Sohini Das | Ahmedabad April 6, 2014 Last Updated at 20:59 IST While big pharma companies are facing hurdles on the export growth front thanks to the issues with the US drug regulator, in ...
 Business Standard1 week ago Domestic drug companies beat MNCs in growth during 2013  Business Standard1 month ago Local drug firms beat MNCs in growth during 2013  Business Standard India1 month ago

GSK says its Calpol suspension outside DPCO, state FDA disputes

In order to counter Maharashtra Food and Drug Administration (FDA) action of stop sale order for paracetamol brand Calpol 60 ml syrup on account of overpricing, GlaxoSmithKline claims that therapeutic dose of Calpol suspension of 120 mg/ 5ml which ...
 PharmaBiz3 weeks ago Maha FDA cancels license of C&F agent for violation of DPCO  PharmaBiz1 month ago Maha FDA inspectors to seize stocks of over priced Calpol suspension from market  PharmaBiz4 days ago State FDA to approach NPPA for overpricing of Calpol  Times of India1 week ago
Money Control

GSK Consumers Crocin Advance set to get cheaper

Crocin Advance prices will now be lowered nationwide below 94 paise per tablet, the ceiling price under DPCO 2013. The regulator will also initiate action against the company for overcharging consumers and recover the overcharged amount.
 Money Control3 weeks ago GSK Consumer's Crocin Advance set to get cheaper  Money Control3 weeks ago
IndiaTV News

Government defends move to cap condom prices

The central government Tuesday defended its decision to bring condoms under the Drug Price Control Order (DPCO), which has put a cap on prices of all male contraceptives in the country.Delhi High Court's acting Chief Justice B.D. Ahmed and Justice Sidharth ...
 Prokerala3 weeks ago

Small drug firms fear margin erosion will impact long-term growth

A decision by Indian drugmakers to revert to old trade margins for drugs listed under the Drug Price Control Order (DPCO) is expected to result in margin erosion for small and mid-sized companies, Business Standard reported Monday. Kamlesh Patel, ...
 FirstWord Pharma1 month ago

IDMA to organise conference on 'Current Challenges & Opportunities in Pharma Marketing'

Details Category: Latest Updates Published on Friday, 18 April 2014 13:23 The theme of the conference is 'Indian Pharmaceuticals for Global Health.' Indian Drug Manufacturers Association (IDMA) will organise pharma marketing ...
 Express Pharma5 hours ago

Drug firm recalls Crocin, Calpol after FDA order

GlaxoSmithKline (GSK) has launched a nationwide recall of its widely sold paracetamol brands like Crocin Advance and Calpol suspension from the retailers, after the Maharashtra FDA ordered to stop sale due to overpricing. Earlier, the state FDA had seized 6, ...
 Asian Age10 hours ago Chemists dispense alternate brands following FDA's action on Crocin Advance  PharmaBiz1 day ago GSK starts nationwide recall of Crocin Advance following state FDA's stop sale order  PharmaBiz1 week ago After Crocin Advance, Calpol under regulatory lens  Business Standard India3 weeks ago

Bulk drug prices may rise this fiscal

While bulk drug exports from India have been on a slow lane last fiscal, the domestic market, nonetheless, is likely to see some price rise this year. The industry feels that prices of active pharmaceutical ingredients (APIs) can go up in the range of 5-15 per cent primarily to factor in inflation, and also because these have now been freed from price control.  The domestic bulk drug industry, however, also points out in the same breath that thanks to stiff competition in the domestic ...
 Rediff.com3 days ago Bulk drug prices likely to increase this fiscal  Business Standard India4 days ago
Business Standard India

Pharma sector expects strong FY15

Rise in prices and volumes expected, with lower import material cost Sohini Das | Ahmedabad April 13, 2014 Last Updated at 23:40 IST The country's pharmaceutical industry expects to be back on a strong growth path in 2014-15, after a tough year ...
 Business Standard India4 days ago Strong Q3 performance helps pharma stocks peak  The Financial Chronicle1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - dpco
Get updated on latest news & your favorite topics right in your inbox!
More     Less